News

Triglide is a fibric acid derivative, which is an adjunctive therapy to diet for high cholesterol and high levels of triglyceride in the blood. First Horizon licensed the

Under the collaboration scientists will use Orion’s methylation technologies to identify biomarkers useful in the detection and treatment of cancers of the lung, breast and ovaries. Methylation refers

In one double-blind, placebo-controlled study in irritable bowel syndrome (IBS), 57% of the participants noted a significant reduction in abdominal pain and bloating after taking Ganeden’s IBS treatment,

After identifying NTx-265 as its lead compound, completing dosing in a phase I study, and raising $8.5 million in an initial public offering, Stem Cell Therapeutics (SCT) has

ATL-962, discovered by Alizyme, is an inhibitor of gastrointestinal lipases and an agent to treat obesity and diabetes. It is designed to cause weight loss by reducing the

The trial will take place in the US and Canada investigating the safety, tolerability and efficacy of EDP-420, an investigational bridged bicyclic macrolide antibiotic for the treatment of

The study evaluated the effects of a single dose of Merck & Co’s Zocor (simvastatin), Pfizer’s Lipitor (atorvastatin calcium), and Kos Pharmaceuticals’ Niaspan (niacin) on the pharmacokinetics and

The study, being funded by a Small Business Technology Transfer (STTR) grant totaling $1.4 million, will assess adult derived hemangioblasts (stem cells) in chronic ischemia, a serious form

Pfizer’s net income for Q4 2005 fell 3% to $2.7 billion, compared to Q4 2004, with revenue for the quarter down 9% compared to the previous year. However,